miR-200c Suppresses Stemness And Increases Cellular Sensitivity To Trastuzumab In HER2+ Breast Cancer
Cailu Song, Jin Wang, Hua Wang, Peng Liu, Longzhong Liu, Lu Yang, Hailin Tang, Xiaoming Xie
This study shows miR-200c reduces stemness and enhances trastuzumab sensitivity in HER2+ breast cancer cells and their stem-like populations.
bioRxiv · Apr 25, 2017 · PreprintCancer Biology